REFERENCES
- Pichot P.. The concept of ‘bouffee delirante’ with special reference to the Scandinavian concept of reactive psychosis. Psychopathology. 1986; 19: 35–43. [PUBMED], [INFOTRIEVE]
- Manschreck T C, Petri M.. The atypical psychoses. Cult Med Psychiatry. 1978; 2: 233–68. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wig N N, Parhee R.. Acute and transient psychoses: a view from the developing countries. Mezzich J E, von, Granach M. International classification in psychiatry. Cambridge, Cambridge University Press. 1987; 115–21
- Menuck M, Legault S, Schmidt P, Remington G.. The nosologic status of the remitting atypical psychoses. Compr Psychiatry. 1989; 30: 53–73. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stromgren E.. The development of the concept of reactive psychoses. Psychopathology. 1986; 20: 62–7
- Wimmer A.. Psykogene Sindssygdomsformer [Psychogenic varieties of mental diseases]. Wimmer A. St. Hans Hospital 1816–1915. Copenhagen, GEC Gads Forlag. 1916; 85–216
- Langfeldt G.. The schizophreniform states. Copenhagen, Munksgaard. 1939
- Leonhard K.. Cycloid psychoses—endogenous psychoses which are neither schizophrenic nor manic-depressive. J Ment Sci. 1961; 197: 632–48
- Perris C.. The importance of Karl Leonhard's classification of endogenous psychoses. Psychopathology. 1990; 23: 282–90. [PUBMED], [INFOTRIEVE]
- Brockington I F, Perirs C, Kendell R E, Hillier V E, Wainwright S.. The course and outcome of cycloid psychosis. Psychol Med. 1982; 12: 97–105. [PUBMED], [INFOTRIEVE]
- Susser E, Finnerty M T, Sohler N.. Acute psychoses: a proposed diagnosis for ICD-11 and DSM-V. Psychiatr Q. 1996; 67: 165–76. [PUBMED], [INFOTRIEVE]
- Cooper J E, Jablensky A, Sartorius N.. WHO collaborative studies on acute psychoses using the SCAAPS Schedule. Stefanis C N, Rabavilas A D, Soldatos C R. Psychiatry: a world perspective. Amsterdam, Elsevier Science. 1990; 185–92
- Susser E, Varma V K, Malhotra S, Conover S, Amador X.. Delineation of acute and transient psychotic disorders in a developing country setting. Br J Psychiatry. 1995; 167: 216–9. [PUBMED], [INFOTRIEVE]
- Malhotra S, Varma V K, Misra A K, Das S, Wig N N, Santosh P J. Onset of acute psychotic states in India: s study of sociodemographic, seasonal and biological factors. Acta Psychiatr Scand. 1998; 97: 125–31. [PUBMED], [INFOTRIEVE]
- Susser E, Wanderling J.. Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Arch Gen Psychiatry. 1994; 51: 294–301. [PUBMED], [INFOTRIEVE]
- Susser E, Fenning S, Jandorf L, Amador X, Bromet E.. Epidemiology, diagnosis, and course of brief psychoses. Am J Psychiatry. 1995; 152: 1743–8. [PUBMED], [INFOTRIEVE]
- Jorgensen P, Bennedsen B, Christensen J, Hyllested A.. Acute and transient psychotic disorder: comorbidity with personality disorder. Acta Psychiatr Scand. 1996; 94: 460–4. [PUBMED], [INFOTRIEVE]
- Good B.. Medicine, rationality, and experience. an anthropological perspective. Cambridge, Cambridge University Press. 1994
- Masliah E, Ge N, Mucke L.. Pathogenesis of HIV-1-associated neurodegeneration. Crit Rev Neurobiol. 1996; 10: 57–67. [PUBMED], [INFOTRIEVE]
- Zink W E, Zheng J, Persidsky Y, Pouekotva L, Gendelman H E. The neuropathogenesis of HIV-1 infection. FEMS Immunol Med Microbiol. 1999; 26: 233–41. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Childs E A, Lyles R H, Selnes O A, et al, Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999; 52: 607–13. [PUBMED], [INFOTRIEVE]
- Cunningham P, Smith D, Satchell C, Cooper D A, Brew B J. Evidence for independent development of RT inhibitor (RTI) resistance patterns in cerebrospinal fluid (CSF) compartment [Abstract 32284]. XII International AIDS Conference. GenevaSwitzerland June–July 1998
- Inkina N, Price R W, Barbour J, et al, HIV-1 compartmentalization and discordant virologic failure in CSF and plasma [Abstract 297]. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, IL January–February 1999
- McArthur J C, McClernon D R, Cronin M F, et al, Relationship between human immunodeficiency virus associated dementia and viral load in cerebrospinal fluid and brain. Ann Neuro. 1997; 42: 689–98
- McClernon D R, Lanier R, Feaser P, et al, HIV in the brain: RNA levels and patterns of zidovudine resistance. Neurology. 2001; 57: 1396–401. [PUBMED], [INFOTRIEVE]
- Swindells S, Zheng J, Gendelman H E. HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions. AIDS Patient Care STDS. 1999; 3: 153–63
- Sidtis J J, Gatsonis C, Price R W, et al, Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled clinical trial. AIDS Clinical Trials Group. Ann Neurol. 1993; 33: 343–9. [PUBMED], [INFOTRIEVE]
- Brew B J, Brown S J, Catalan J, et al, Safety and efficacy of abacavir in AIDS dementia complex [Abstract]. XII International AIDS Conference. GenevaSwitzerland June–July 1998
- Monteforte A, Musicco M, Galli M, et al, Italian multicenter study of didanosine compassionate use in advanced HIV infection. Eur J Microb Infect Dis. 1997; 16: 135–42
- Pizzo P A, Butler K, Balis F, et al, Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1990; 117: 799–808. [PUBMED], [INFOTRIEVE]
- Thomas S A, Segal M B. The transport of the anti-HIV drug, 2′,3′-didehydro-3′-deoxythymidine (D4T), across the blood brain and blood-cerebrospinal fluid barriers. Br J Pharmacol. 1998; 125: 49–54. [PUBMED], [INFOTRIEVE]
- Enting R H, Hoetelmans R MW, Lange Joep MA, Burger D M, Beijn J H, Portegies P.. Antiretroviral drugs and the central nervous system. AIDS. 1998; 12: 1941–55. [PUBMED], [INFOTRIEVE]
- Martin C, Sonnerborg A, Svensson J O, Stahle L.. Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system. AIDS. 1999; 13: 1227–32. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goodkin K, Baldewicz T T, Wilkie F L, Tyll M D. Cognitive-motor impairment and disorder in HIV-1 infection. Psychiatr Ann. 2001; 31: 37–44
- Goodkin K, Baldewicz T T, Wilkie F L, Tyll M D, Shapshak P.. HIV-1 infection of the brain: a region-specific approach to its neurophysiology and therapeutic prospects. Psychiatr Ann. 2001; 31: 182–92
- Rabkin J G. Prevalence of psychiatric disorders in HIV illness. Int Rev Psychiatry. 1996; 8: 157–66
- Lyketsos C G, Hanson A L, Fishman M, McHugh P R, Treisman G J. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med. 1994; 24: 103–13. [PUBMED], [INFOTRIEVE]
- Atkinson J H, Jr, Grant I, Kennedy C J, et al, Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: a controlled study. Arch Gen Psychiatry. 1988; 45: 859–64. [PUBMED], [INFOTRIEVE]
- Brown G R, Rundell J R, McManis S E, Kendall S N, Zachary R, Temoshok L.. Prevalence of psychiatric disorders in early stages of HIV infection. Psychosom Med. 1992; 54: 588–601. [PUBMED], [INFOTRIEVE]
- McDaniel J S, Fowlie E, Summerville M B, Farber E W, Cohen-Cole S A. An assessment of rates of psychiatric morbidity and functioning in HIV disease. Gen Hosp Psychiatry. 1995; 17: 346–52. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lyketsos C G, Hutton H, Fishman M, Schwartz J, Treisman G J. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996; 10: 1033–9. [PUBMED], [INFOTRIEVE]
- Boggs W.. Depression impairs adherence to HAART regimen by HIV-infected women. J Acquir Immune Defic Syndr. 2002; 30: 401–9
- Evans D L, Ten, Have T R, Douglas S D, et al, Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002; 159: 1752–9. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Donlon P T, Hopkin J, Tupin J P. Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol. Am J Psychiatry. 1979; 136: 273–8. [PUBMED], [INFOTRIEVE]
- Belmaker R H, Lerner Y, Ebstein R P. Rapid neuroleptization reconsidered. Am J Psychiatry. 1980; 137: 129–30. [PUBMED], [INFOTRIEVE]
- Peuskens J.. Good medical practice in antipsychotic pharmacotherapy. Int Clin Psychopharmacol. 1998; 13(suppl 3)S35–41. [PUBMED], [INFOTRIEVE]
- Centorrino F, Eakin M, Bahk W, et al, Inpatient antipsychotic drug use in 1998, 1993 and 1989. Am J Psychiatry. 2002; 159: 1932–5. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sturm R, Bao Y.. Datapoint: psychiatric care expenditures and length of stay: trends in industrialized countries. Psychiatr Serv. 2000; 51: 295, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kapur S.. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003; 160: 13–23. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Boronow J J. Physician or payer: who determines length of stay?. Psychiatr Serv. 2001; 52: 1299–305. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rosenberg S D, Mueser K T, Friedman M J, et al, Developing effective treatments for post-traumatic disorders among people with severe mental illness. Psychiatr Serv. 2001; 52: 1453–61. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hendryx M S, Rohland B M. Psychiatric hospitalization decision making by CMHC staff. Community Ment Health J. 1997; 33: 63–73. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Huntley D A, Cho D W, Christman J, Csernansky J G. Predicting length of stay in an acute psychiatric hospital. Psychiatr Serv. 1998; 49: 1049–53. [PUBMED], [INFOTRIEVE]
- Rosenquist P B, Colenda C C, Briggs J, Kramer S I, Lancaster M.. Best practices: using case vignettes to train clinicians and utilization reviewers to make level-of-care decisions. Psychiatr Serv. 2000; 51: 1363–5. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sowers W, Pumariega A, Huffine C, Fallon T.. Level-of-care decision making in behavioral health services: The LOCUS and the CALOCUS. Psychiatr Serv. 2003; 54: 1461–3. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ford W E. Medical necessity: its impact in managed mental health care. Psychiatr Serv. 1998; 49: 183–4. [PUBMED], [INFOTRIEVE]
- Simon R I. Psychiatrists awake! Suicide risk assessments are all about a good night's sleep. Psychiatr Ann. 1998; 28: 479–84